CLINICAL_TRIALS
trial_result
· 2016-11-25
Clinical Trial Update: Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial [Phase 3]
Summary
Open-label extension update for a Phase 3 trial in epilepsy evaluating VRX-RET-E22-301; results posted after trial completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2016-11-25